BriaCell closes $30M public offering of units; warrants trade under BCTXL

BriaCell Therapeutics Corp.

Closed public offering of 5,366,726 units at $5.59/unit for gross proceeds of ~$30M.
Each unit comprises one common share (or pre-funded warrant) and one warrant at $6.93.
Warrants started trading on Nasdaq on Jan 14 under symbol BCTXL; expire in 5 years.
Net proceeds to fund working capital, general corporate purposes, and business advancement.
Placement agent warrants issued to ThinkEquity for 161,001 shares at $8.385 per share.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BriaCell Therapeutics Corp. entered into Warrant Agent Agreement with Computershare Inc. and Computershare Trust Company, N.A. (effective 2026-01-15).

Action: entry
Counterparty: Computershare Inc. and Computershare Trust Company, N.A.
Effective: 2026-01-15

Exact text from the filing

On January 15, 2026, the Company also entered into a Warrant Agent Agreement (the “Warrant Agent Agreement”) with Computershare Inc. and Computershare Trust Company, N.A. (“Computershare”), pursuant to which Computershare agreed to act as transfer agent with respect to the Warrants.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BriaCell Therapeutics Corp. entered into Placement Agency Agreement with ThinkEquity LLC valued at $30 million (effective 2026-01-13).

Action: entry
Agreement: underwriting
Counterparty: ThinkEquity LLC
Value: $30 million
Effective: 2026-01-13

Exact text from the filing

On January 13, 2026, the Company entered into a Placement Agency Agreement (the “Placement Agency Agreement”) with ThinkEquity LLC (the “Placement Agent”), pursuant to which the Company agreed to issue and sell directly to investors, in a best efforts basis the Common Units and the Pre-funded Units.

View on SEC.gov

294 material agreements filed in the last 30 days. Browse all material agreements →

BriaCell Therapeutics Corp. filing history →

Source: SEC EDGAR

accession 0001493152-26-002430

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.